Peter L. Elkin, MD, UB Distinguished Professor and chair of biomedical informatics at the Jacobs School of Medicine and Biomedical Sciences, has been awarded an R25 grant from the National Institutes of Health’s National Library of Medicine (NLM) to train underrepresented minorities in biomedical informatics and data science.
Multiple sclerosis (MS) patients may be better equipped to stave off the cognitive decline that the disease can cause by using a smartphone-based app now under development at the Jacobs School of Medicine and Biomedical Sciences.
Peter L. Elkin, MD, UB Distinguished Professor and chair of biomedical informatics at the Jacobs School of Medicine and Biomedical Informatics, has received two prestigious honors.
Nineteen faculty members with clinical and research experience have joined the departments of Biomedical Informatics, Family Medicine, Medicine, Orthopaedics, Pathology and Anatomical Sciences, Pediatrics, Physiology and Biophysics, and Psychiatry.
The Jacobs School of Medicine and Biomedical Sciences hosted the 2022 National Library of Medicine (NLM) T15 Informatics Training Conference June 22-24.
Seven of the 20 UB faculty and staff members who have been named recipients of the 2022 SUNY Chancellor’s Award for Excellence have connections to the Jacobs School of Medicine and Biomedical Sciences.
Twenty-eight doctoral, 62 master’s and 205 baccalaureate candidates were eligible to receive degrees in biomedical science fields during the May commencement ceremony.
Patients hospitalized with COVID-19 pneumonia had a 13.5% survival advantage when treated with a combination of leukotriene inhibitors (LTIs) and the steroid dexamethasone.
The International Organization for Standardization and the International Electrotechnical Commission have approved Basic Formal Ontology as having met international standardization criteria for Top-Level Ontologies; this is the first piece of philosophy to have been accepted through a standardization process of this sort.
A team of researchers in the Jacobs School of Medicine and Biomedical Sciences have developed a new, high-throughput screening method designed to quickly screen antiviral candidates against the SARS-CoV2 virus.
